Global Cord Blood Corporation Overview
Pro stress-test →Global Cord Blood Corporation provides umbilical cord blood storage and ancillary services in China, offering blood collection, laboratory testing, hematopoietic stem cell processing and stem cell storage services. The company operates a network of cord blood banks and holds the world's largest inventory of stored cord blood units.
Strategic Profile
Pro stress-test →The company holds exclusive licenses for cord blood banking in Beijing (since 2002), Guangdong (since 2006), and Zhejiang (since 2010). This monopoly position in three major Chinese provinces with 1.8 million annual births provides significant market protection and recurring revenue potential from subscription-based cord blood storage services.
Competitive Landscape
Pro stress-test →Global Cord Blood operates in a highly regulated Chinese cord blood banking market with government-mandated single-license-per-province restrictions. Main competitors are other licensed cord blood banks in China (operating in provinces outside its footprint) and alternative cell banking providers. The company's competitive advantage rests solely on exclusive provincial licenses rather than operational excellence or innovation.
Industry Context
Global Cord Blood Corporation operates in Biotechnology / Life Sciences (Cord Blood Banking & Stem Cell Storage).
Key facts
Founded: 2008 · Headquarters: Central, Hong Kong · Employees: 1,202 · Revenue: N/A · Market cap: $0.10B